PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Proquest Summons
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Enrico Balleari
Enrico Balleari
IRCCS AOU San Martino-IST, Largo R. Bensi 10, 16132 Genova,
Italy
Publications
-
Review Article
Iron Overload and Iron-Chelation Therapy in Patients with Myelodysplastyc Syndromes
Author(s): Lisette Del Corso, Eleonora Arboscello and Enrico BalleariLisette Del Corso, Eleonora Arboscello and Enrico Balleari
Transfusion-dependency is an independent prognostic factor for survival in myelodysplastic syndromes (MDS). This negative impact is mainly due to the iron overload (IOL) consequent in large part to chronic transfusion therapy because of its detrimental effects on cardiac, hepatic and endocrine functions. The main tools useful for clinical diagnosis and monitoring of IOL should be serum ferritin, transferrin saturation and magnetic resonance imaging. If correctly evaluated, IOL is frequently observed in lower-risk MDS patients, and is more pronounced in longer surviving individuals. A detrimental role of IOL in MDS patients has been documented in several studies, showing a correlation with a shorter overall survival. Treatment of IOL with iron chelating therapy (ICT) has been shown to prevent at least in part these negative effects. The goal of ICT in MDS patients is to prevent and tre.. View More»
DOI: 10.4172/2155-9864.1000175